Changes in the hormone producing pancreatic islet cells are culprits in the development of diabetes, and these changes are often reflected by changes in expression of key genes. Analysis of such changes require advanced bioinformatics tools that can translate the process into simple visible information. To achieve these goals we have developed a tool called Islet Gene View (IGW), that aims to make information on gene expression in human pancreatic islets from organ donors easily accessible to the scientific community. Islet Gene View currently consists of information on islets from 188 donors where data on RNA expression of more than 15 000 genes can be related to phenotypic information (gender, age, BMI, HbA1c, insulin and glucagon secretion etc.). Also this information can be related to expression other genes and how gene expression is regulated by genetic variants(so called eQTLs, expression Quantitative Traits) The data will be accessible thorugh the easy-to-use Islet Gene View web application.
Introduction
Gene expression analysis provides a link between genetics and cellular function and is crucial for the elucidation of pathophysiological mechanisms. Information on gene expression in different tissues has been instrumental to the scientific community. The Genotype-Tissue Expression (GTEx) project (2013) has provided a pioneering example on how to share information from deceased humans. Unfortunately, GTEx has limited information on human pancreatic islets of Langerhans, as sequencing has only been performed on whole pancreas from a limited number of deceased donors. Importantly, the pancreas needs to be removed while blood flow is still intact to retain functionality of the pancreatic cells, and therefore more information on human pancreatic islets can be derived from organ donors for transplantation purposes where blood flow still has been kept intact.
The Human Tissue Laboratory (HTL), which was created as part of a collaboration between Uppsala and Lund universities and funded by a strategic research grant, i.e. the Excellence of Diabetes Research in Sweden (EXODIAB), has generated a large repository of tissue samples (human pancreatic islets, fat, liver and muscle) from deceased organ donors. Here, we leveraged gene expression (RNA sequencing) and genome wide genetic variation data (GWAS) from human pancreatic islets to elucidate gene expression modulation in relation to T2D status, as well as analysis of effects of genetic variation on gene expression, i.e. eQTLs (Expression Quantitative Traits).
Additionally, gene expression can be explored in relation to gender, BMI, and age as well as glucose-stimulated insulin secretion and expression of other pancreatic hormones. To provide rapid and robust overview of the data, as well as "look-ups", for scientists in EXODIAB, a web-based tool, Islet Gene View, was created and will be made available to the scientific community.
Materials and methods

Sample acquisition
Human pancreatic islets (n = 188), fat (n = 12), liver (n = 12) and muscle (n = 12) were obtained through the EXODIAB network from the Nordic Transplantation Program 4 (http://www.nordicislets.org). The isolation of total RNA including miRNA was carried out using the miRNeasy (Qiagen) or the AllPrep DNA/RNA (Qiagen) mini kits. The quality of isolated RNA was controlled using a 2100 Bioanalyzer (Agilent Technologies) or a 2200 Tapestation (Agilent Technologies) and quantity was measured using NanoDrop 1000 (NanoDrop Technologies) or a Qubit 2.0 Fluorometer (Life Technologies). Clinical characteristics of the donors are shown in Supplementary Table 1.
Islet Phenotypes
Purity of islets was assessed by dithizione staining, and estimates of the contribution of exocrine and endocrine tissue was assessed as previously described (Friberg et al., 2011 ).
Phenotypic information:: Diagnosis of Type 2 diabetes (T2D) was either based on an existing clinical diagnosis of T2D (N = 33) or on an HbA1c above 6.5% (NGSP units; equal to 48 mmol/mol in IFCC) (N = 25). IGT was defined as HbA1c between 6 and 6.5% (N = 30).
BMI and gender information was obtained from donor records. Stimulatory index (SI) was
used as a measure of glucose-stimulated insulin secretion. For this purpose islets were subjected to static perfusion of glucose, which was raised from 1.67 to 16.7 mmol/l; insulin was measured at both high and low glucose. The fold change in insulin levels between the two conditions was used as a measurement of glucose-stimulated insulin secretion.
Sample preparation for sequencing
One µg of total RNA of high quality (RIN>8) was used for sequencing with a TruSeq RNA sample preparation kit (Illumina). The size selection was made by Agencourt AMPure XP beads (Beckman Coulter) aiming at a fragment size above 300 bp. The resulting libraries were quality controlled on a 2100 Bioanalyzer and a 2200 Tapestation (Agilent Technologies) before combining 6 samples into one flow cell to be sequenced using a HiSeq 2000 sequencer (Illumina).
Data analysis
The raw data were base-called and de-multiplexed using CASAVA 1.8.2 (Illumina) before alignment to hg38 with STAR version 2.4.1. To count the number of reads aligned to specific transcripts, featureCounts (v 1.4.4) (Liao et al., 2014) was used, with GENCODE version 22 as gene, transcript and exon models.
Raw data were normalized using trimmed mean of M-values (TMM) and transformed into log 2 counts per million (log 2 CPM), using voom (Law et al., 2014) before linear modeling.
Samples with less than 10 million reads in total were excluded from further analysis. In addition, genes with lower than 1 CPM in at least 10 samples were also excluded, leaving 15,017 genes for analysis in the 188 samples. After TMM-normalization, the data were adjusted for batch effects using ComBat (Combatting batch effects when combining batches of microarray data) from the sva (surrogate variable analysis) R package (Leek et al., 2012) . The effective length of each gene in each sample was calculated using RSEM (Li and Dewey, 2011) . The resulting CPM values were converted into FPKM values by dividing the transcripts by their effective lengths and multiplying with 1000.
A potential association between gene expression and phenotypes was analyzed by linear modeling. P-values were calculated using the eBayes function in limma (Ritchie et al., 2015) , and P-values adjusted for multiple testing were calculated across all genes using Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) .
As expression of 53% of the genes in the dataset was correlated with purity (mostly due to admixture of exocrine tissue), we included purity as a covariate in the linear models for all association analyses, together with sex and age. Six individuals were found to not have a type 2 diabetes diagnosis but have HbA1c of above 6.5%. The six individuals were excluded from the differential expression analysis of type 2 diabetes versus controls to avoid potentially contaminating the control group with potential undiagnosed diabetes cases.
An empirical and conservative approach was used to calculate P-values for gene-gene ). Based on these calculations, the observed data were used for the calculation of P-values. For all target secretory genes, P-values of correlations were calculated using the pnorm (probability of normal distribution) function in R (R Core Team, 2016) using the estimated parameters.
Depending on negative or positive correlations, the lower or the upper tail of the distribution was used for testing.
As a way to investigate the biological relevance of the RNA-Seq and eQTL data, we investigated the relationship between previously known risk variants and gene expression in Geneview. For a list of 404 variants previously associated with either T2D risk (Mahajan et al., 2018) or with β cell function, we identified all variants which were nominally significant eQTLs in the islets. For each eQTL, the targeted gene was extracted.
The list of genes affected by eQTLs was tested for enrichment of genes whose expression was correlated with secretory genes using bootstrapping. This was done by repeatedly selecting random sets of genes of the same size(10 000 iterations). The mean empirical P-value for each run was then calculated which was used as a null distribution to calculate the probability of the observed mean P-value in the observed set of genes.
Results
Differentially expressed genes between T2D and non-diabetic donors
In order to study global gene expression in human pancreatic islets, we performed RNA sequencing on 188 islets from organ donors using Illumina's HiSEQ platform. The average number of counts mapped to genes was 26.1 million reads (± 13.1 million) ranging from 10. We then stratified our analysis based on Hba1c levels whereby Hba1c > 6.5 were considered T2D, Hba1c between 6% and 6.5% were considered to have IGT and HbA1c < 6 normal glucose tolerance (NGT). Out of a total of 15017 genes 12% were nominally (P<=0.05) significantly DEGs between IGT and NGT; however, these differences did not reach genome-wide significance (FDR <= 0.05). Similarly 11.5% of genes were nominally differentially expressed (P <= 0.05) and notably, only 0.4% (55 genes, Supplementary Of 1619 genes which were found to be nominally significantly associated with HbA1c levels in a previous study based on a subset of the same dataset (ref Fadista et. al) , 36.5% were replicated in this larger dataset as being nominally differentially expressed in either the T2D stratum or the IGT stratum.
Co-expression of genes with expression of islet secretory genes
Pancreatic islets comprise distinct cell types defined by the proteins they secrete; alpha cells secrete glucagon, beta cells secrete insulin and islet amyloid polypeptide (IAPP), delta cells secrete somatostatin, and F cells (also called PP cells) secrete pancreatic polypeptide Y. We therefore also performed a co-expression analysis of all genes with these 5 secretory genes including insulin (INS, Figure 1I ), glucagon (GCG, Figure 1J ), somatostatin (SST, Figure 1K ), islet amyloid polypeptide (IAPP, Figure 1L ), and pancreatic polypeptide Y (PPY, Figure 1M ). Table 5 
INS expression was correlated with the largest number of genes expressed in human pancreatic islets (Supplementary
Expression quantitative traits (eQTLs)
In order to explore the effect of genetic variation on gene expression in human pancreatic islets, we performed eQTL analysis using GWAS data imputed with the 1000 Genomes Phase I (March 2012) integrated variant set reference panel and RNA data from the 188 donors. The effect of SNPs proximal to a given gene on its expression was computed by cis-eQTL analysis using Matrix eQTL. For this analysis, only cis-eQTLs located within 2 Mb of the target genes were considered.
13 296( 95% ) of all genes had at least one nominally significant eQTL( P < 0.05), and 25% had at least one genome-wide significant eQTL (FDR <= 0.05) adjusted for all tested variants. The five strongest eQTLs were seen in the ERAP2, ERV3-1, XRRA1, XKR9, and ASAH2 genes (Supplementary Figure 1) . Among the 80 top DEGs across all phenotypes, 58 had at least one genome-wide significant eQTL (FDR <= 0.05). Among all studied genes, 3494 genes (23.2%) had at least one genome-wide significant eQTL and 13993 (93.2%) had at least one nominally significant eQTL.
Integration of gene expression in islets with T2D risk variants
Previous GWAS studies have reported 404 unique variants associated with T2D risk (Mahajan et al., 2018) . These 404 SNPs resulted in a list of 383 target eGenes (genes whose expression is influenced by genetic variants), 41 of which were specifically related to general β-cell function. To further elucidate the role of these genes in T2D, we showed by enrichment analysis and bootstrapping these 383 eGenes, enrichment was significant for co-expression with INS but not with GCG or SST expression ( figure 3A ). For the list of β-cell related genes, enrichment was significant for INS as well as GCG. Genes which were significantly positively co-expressed with INS or SST(empirical P <= 0.05) tended to be upregulated in T2D ( Figure 3B ), and conversely negatively co-expressed genes were downregulated in T2D. GCG showed the opposite pattern; genes positively co-expressed with GCG were downregulated in T2D and vice versa.
Four genes were found to be both nominally significant eGenes in islets and downregulated in T2Ds -CYB561, PKIG, PEX16, CKB and PTGDS. Similarly 3 genes were eGenes in islets and downregulated in T2D -GPRC5D-AS1, PARP14, and SNAP23.
In order to functionally annotate all genes expressed in human pancreatic islets we created the Islet Gene View (IGW) web tool (see below).
Islet Gene View (IGW) -Features
Islet Gene View (IGW) will be accessible on the web page after a free registration process. IGW uses several common gene identifiers (e.g. gene symbol, Ensembl gene ID, and full gene name), and provides graphs of gene expression in relation to islet phenotypes and expression of other genes. Gene expression can be related to diabetes-related phenotypes such as age, BMI, and a diagnosis of T2D, as well as glucose tolerance defined by HbA1c strata (normal glucose tolerance, NGT: HbA1c <6%, impaired glucose tolerance, IGT: HbA1c between 6-6.5%, and T2D: HbA1c > 6.5%). Of interest is also co-expression of other cell-specific genes such as insulin (INS), glucagon (GCG) and islet amyloid polypeptide (IAPP). The Ensembl gene ID is the primary key identifier for the expression database, and additional gene identifiers and other annotations were derived from Ensembl using the biomaRt API (Durinck et al., 2009 ). In addition to islet gene expression data, a 12-donor tissue panel of biopsies from fat, islets, liver and skeletal muscle are used to provide a comparison of gene expression in different tissues. Top 10 genes associated with islet phenotypes are shown in supplementary table 7.
As an example we here show one of the genes found to both be an eGene targeted by a T2D risk variant as well as being differentially upregulated in T2D vs NGT (PTGDS, SNAP23 and KCNQ1).
PTGDS
In the integrative analysis of diabetes risk SNPs, PTGDS (Supplementary Figure 2) came up as the top hit as most strongly associated with T2D, while also being co-expressed with INS and targeted by a diabetes risk SNP eQTL. In Geneview, it is also nominally associated with BMI and HbA1c, and has a genome-wide significant eQTL signal from two linked loci (rs28592848 and rs28375538 ). Figure 3) is another top hit from the integrative analysis of diabetes risk SNPs. In contrast to PTGDS this gene is nominally down-regulated in T2D (as well as in patients with HbA1c >=6.5%) and negatively co-expressed with INS. Additionally it was negatively coexpressed with the SST gene and negatively associated with purity possibly suggesting a higher expression in the exocrine pancreas.
SNAP23
SNAP23 (Supplementary
To further demonstrate the utility of IGW, we generated IGW outputs for a few genes previously implicated in monogenic or polygenic diabetes.
KCNQ1
KCNQ1 expression was strongly negatively correlated with purity suggesting that it is also enriched in the exocrine pancreas (Supplementary Figure 4) . It was significantly downregulated in patients with HbA1c >=6.5% but not in diagnosed T2D patients. Additionally it is negatively coexpressed with the INS gene (p = 0.048). Also, KCNQ1 expression is also nominally influenced by rs8181588, a previously established T2D risk SNP located in an intron of KCNQ1. Figure 5) was highly expressed in islets but not in fat, liver or skeletal muscle. It was also positively correlated with purity and INS expression suggesting that it is a betaspecific gene.
MNX1
MNX1 (Supplementary
PDX1
PDX1 was highly expressed in islets, and correlated positively correlated with islet purity and significantly associated with stimulatory index(P = 0.037) as well as purity (Supplementary Figure   6 ). In addition, it was nominally downregulated in T2D (P = 0.022) and showed strong correlation with HbA1c and BMI.
WFS1
WFS1 (Supplementary Figure 7) was positively correlated with purity and nominally upregulated in IGT but not in T2D patients. Additionally it was positively correlated with INS and SST expression.
All six genes were found to have at least one nominally significant eQTL, with lowest P-values for 6.3e-04 (PDX1), 9.8e-04 (WFS1), 1.2e-03(KCNQ1), 1.8e-03(SNAP23) and 3.2e-03 (MNX1).
The example of CHL1,previously associated with T2D
We also provide an IGW graph for the CHL1 gene (Supplementary Figure 8) , which previously has been shown to be associated with T2D (Belongie et al., 2017) ..Furthermore in keeping with a previous study from our laboratory (Fadista et al. 2014 ) expression of the CHL1 gene was downregulated in T2D islets from this larger data set (Supplementary Figure 2) . Moreover the fasting insulin-associated SNP rs9841287 at the CHL1 locus was found to be an eQTL for the CHL1 and CHL1-AS1 genes (P = 0.028, increasing allele = G). In support of the above findings, it was also negatively associated with high HbA1c.
Expression of the SERPINE2 gene showed the greatest difference between T2D and NGT
The Serpin Family E Member 2 (SERPINE2) gene was selected due to the strong association of its expression with T2D. In addition to having high expression in islets, it is also expressed in adipose tissue, liver and muscle ( figure 1A) . SERPINE2 was also modestly correlated with purity (r2 = 0.064, p = 0.011, figure 1B ).
The expression of the SERPINE2 gene in the islets was greater than e.g. a well-known β-cell gene, the Potassium Voltage-gated Channel Subfamily J Member 11 gene (KCNJ11, rank 40.3%).
The most highly expressed gene in the dataset was the glucagon (GCG) gene, followed by the , log2 fold change = 0.58 or ~150% increase, Figure 1D ). Expression of SERPINE2 showed of all genes the strongest correlation with HbA1c ( r2 = 0.13, Pfdr= 9.5 x 10-7 ).
11
In (Figure 1F ). The most downregulated gene in T2D vs NGT was the Phospholipase A1 Member A (PLA1A) gene (log2 fold change = -1.00, PFDR = 5.9 • 10 -5
).
The Solute Carrier Family 2 Member 2 (SLC2A2) gene (Supplementary Figure 9) , encoding the glucose transporter 2 (GLUT2), showed the strongest negative correlation with HbA1c. In support of this SLC2A2 expression was also lower in islets from T2D vs NGT donors , log2
fold change = -1.08)( Figure 1G ).
Discussion
Islet GeneView (IGW) aims to provide information on gene expression from human islets in combination with diabetes-related phenotypes in islets from individuals with and without T2D.
Thereby, Islet Gene View is complementary to other related databases such as the Islet eQTL explorer (Varshney et al., 2017) , which connects genetic variation to islet gene expression and chromatin states in 112 samples, and GTEx (2013) which comprehensively characterizes the human transcriptome across many tissues, including some whole pancreas samples. GTEx, however, does not provide data on the islet transcriptome, which clearly is very different from that in the exocrine part of the pancreas.
Compared to previous publications on the same dataset (Fadista et al., 2014; Taneera et al., 2012) , the current data set included188 islets from human organ donors, Compared to our previous report (Fadista et al., 2014) , several refinements to the analytical pipeline have been made. We have introduced batch correction using ComBat. In addition, we have refined the methodology for calculating correlation P-values with higher specificity and stringency in detecting potential gene-gene correlations, which are now less dependent on batch effects. This reduces the influence of nonspecific inter-gene correlations resulting from the normalization procedure for gene expression. All gene-gene correlations have been pre-calculated in order to estimate the null distribution of the correlation values. This is computationally intensive, but only has to be done once.
In this new expanded dataset, we identified a total of 215 genes which showed genome-wide t( FDR<=0.05 ) and 6157 genes which showed nominal significance (P<=0.05) when comparing T2D with NGT). For the stratified HbA1c phenotype (T2D,IGT and NGT), 1789 genes were nominal DEGs between the glycemic clusters T2D,IGT and NGT compared with 1619 genes in the previous analysis (Fadista et al., 2014) .
T2D has been ascribed to the inability of pancreatic beta cells to produce sufficient insulin to meet the demands due to increased insulin resistance, therefore human islets are a key tissue in T2D pathogenesis. Genome wide association studies have reported 403 genetic loci association with T2D risk whereas their function is largely unknown. To further leverage this data to elucidate function at previously reported T2D loci, we cross referenced the data with gene expression and eQTL data in IGW to identify genes whose expression is modulated by T2D risk loci and further elucidate their association with islet traits. We here identified multiple gene loci which are transcriptionally regulated by T2D risk loci, which were also differentially expressed in type 2 diabetes patients, and correlated with INS secretion ( Figure 3 ). Two examples of these genes, PTGDS and SNAP23, are described in further detail below. In total, this demonstrates how IGW can be used to identify complex relationships between genetics, transcriptomics and diabetic phenotypes.
The PTGDS gene (Supplementary Figure 3) encodes an enzyme which converts prostaglandin H2 to prostaglandin D2. High PGD2 levels in turn have been found to increase insulin sensitivity (Fujitani et al., 2010) , and knock-out of PTGDS gives the reverse effect resulting in insulin resistance, nephropathy and atherosclerosis through effects on adipose tissue (Ragolia et al., 2005) . While we found little data on the correlation between diabetes and PTGDS in islet cells in previous scientific literature, our results suggests that expression of the gene in islets is correlated both with diabetes status, BMI and INS expression, indicating that PTGDS function and prostaglandin levels may be connected to insulin secretion as well as peripheral insulin resistance.
The SNAP23 (Supplementary Figure 4) protein product is involved in vesicle fusion and is essential for peripheral insulin sensitivity through GLUT4 transportation (Kawanishi et al., 2000) .
The role is reversed in islets, where an endocrine islet-specific knockout of SNAP23 in mice shows improved glucose tolerance and insulin secretion (Kunii et al., 2016) . Our results correlate with these previous findings in islets in several ways -SNAP23 is nominally significantly downregulated in diabetics, negatively correlated with INS expression, and interestingly enough, also negatively correlated with somatostatin expression which has not been previously reported.
We then examined genes previously implicated in monogenic as well as polygenic diabetes using IGW. Monogenic diabetes mutations target genes that are essential for sufficient insulin secretion, while polygenic diabetes genes are more diverse in their different functions. Figure 5) is a voltage-gated potassium channel that affects the repolarization of the islet cell membrane. Earlier studies suggest that KCNQ1 overexpression negatively affects insulin secretion through premature repolarization (Kasuga, 2011) . Our new data shows also a negative correlation with INS expression. The explanation for these somewhat disparate findings is unclear but could involve a compensatory response from the beta cell to slow down repolarization. Figure 6) encodes another transcription factor that is required for beta-cell maturation and maintenance (Spaeth et al., 2017) . We here add new information showing that PDX1 is downregulated in T2D supporting previous findings that its expression correlates with chronic hyperglycemia (Fujimoto and Polonsky, 2009 ) .
KCNQ1 (Supplementary
PDX1 (Supplementary
The WFS1 gene (Supplementary Figure 7) produces the wolframin protein.
Inactivation of WFS1
further increases ER stress through wolframin resulting in progressive beta cell death (Fonseca et al., 2005) . This is also shown in Geneview where WFS1 shows clear positive correlation with INS expression. Interestingly somatostatin is also significantly correlated with WFS1.
Somewhat surprisingly the stimulatory index (SI) did not show genome-wide significant correlation with expression of any gene. There might be several explanations for this. First, although the largest dataset of its kind, we still have limited power to obtain genome wide significance for a crude measure like SI. Despite this, the information may be useful as exploratory information.
IGW provides information on co-expression of genes with secretory genes from α-cells, β-cells, δ-cells, ε-cells and PP-cells. IRF2BP1, a co-repressor of Interferon Regulatory Factor 2 (IRF2) (Mashima et al., 2011) , showed the strongest positive correlation with INS. IRF2 is a transcription factor that suppresses the expression of interferon α and β, which might affect islet cell survival and proliferation. Interestingly, IRF2 is negatively correlated with INS expression in this dataset
The GC-rich promoter binding protein 1 like 1 gene (GPBP1L1) showed the strongest negative correlation with INS expression. While the function of GPBP1L1 is unknown, it likely acts as a transcription factor, like its paralogous gene GPBP1 (Hsu et al., 2003) . This could indicate that Therefore, the G9a/GLP complex might act as a switch that regulates the balance between insulin and glucagon secretion and has been shown to affect insulin signaling in the liver (Xue et al., 2018) . NUDC and KLHL21 play important roles in cell division and could possibly influence the mass of a particular cell population. IMP4 affects pre-rRNA processing and thus production of ribosomes. ISG20 is an exoribonuclease that is stimulated by interferons, and ZNF787 is a gene with unknown function.
SLC2A2, encoding the glucose transporter GLUT2 plays a key role in islet function (Thorens, 2015) . Its expression was downregulated already in patients with IGT and even more so in T2D.
Common variants in SLC2A2 associate with T2D, fasting glucose and HbA1c as well as insulin secretion in previous GWAS (Manning et al., 2012; Scott et al., 2017) . Down-regulation of SLC2A2 could be epigenetically mediated as it has been shown to be methylated in islets from patients with T2D (Volkov et al., 2017) . Common variants in SLC2A2 also associate with the response to metformin (Zhou et al., 2016) .
The SNP rs9841287 in the CHL1 gene has previously been associated with fasting insulin concentrations, with the A allele (Frequency = 0.69 in 1000 Genomes) increasing insulin levels i (P = 7.78 • 10 -9
) (Manning et al., 2012; Scott et al., 2017) ).The IGW data suggest that high expression 15 of CHL1 in islets could have beneficial effects on beta-cell function.
An important aspect of Islet Gene View is that it can compare expression of different genes as simple histograms. The most highly expressed genes in islets were GCG, followed by REG1A,
MT-CO1 and MT-ATP6. While the comparability between genes is higher with RNA-Sequencing than with microarrays, the gene sequence might influence the sequencing rate of different transcripts. Information on purity provides allows for a partial separation of expression patterns in endocrine and exocrine tissue.
Taken together Islet Gene View is a tool to facilitate research on human pancreatic islets to and is therefore made accessible to the entire scientific community. However, we need to remember that it has limitations, it is based upon a relatively small sample size of islets from patients recruited through intensive care units. The data are observational, but cannot distinguish correlation from causation. However, the exploratory use of IGW could help designing more comprehensive functional follow-up studies.
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